Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ: CDNA )

24.50 -0.34 (-1.37%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
Independent Prospective Study Defines Reference Range for CareDx’s AlloSure for Long-Term Lung Transplant Surveillance
From CareDx, Inc.
Via Business Wire
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
From CareDx, Inc.
Via Business Wire
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
Don’t Put CareDX Stock in Your Portfolio’s Pipeline
Unfortunately, CDNA stock is a losing investment in a company with an interesting concept but poor financial execution. 
Via InvestorPlace
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
CareDx To Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
CareDx Reports Third Quarter 2022 Results
From CareDx, Inc.
Via Business Wire
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
From CareDx, Inc.
Via Business Wire
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
From CareDx, Inc.
Via Business Wire
CareDx to Report Third Quarter 2022 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting
From CareDx, Inc.
Via Business Wire
5 Top Stocks Cathie Wood Is Buying This Week
There's a new Ark fund in town, and its name is the ARK Venture Fund. It will capitalize on democratizing private investments to the public. 
Via InvestorPlace
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
From CareDx, Inc.
Via Business Wire
Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions
From CareDx, Inc.
Via Business Wire
CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List
From CareDx, Inc.
Via Business Wire
NASDAQ: CDNA Long Term Investor Alert: Investigation of Potential Wrongdoing at CareDx, Inc
San Diego, CA -- (SBWIRE) -- 09/19/2022 -- Certain directors of CareDx, Inc are under investigation over potential breaches of fiduciary duties by certain directors of CareDx, Inc. 
Via SBWire
CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference
From CareDx, Inc.
Via Business Wire
Cathie Wood Buys Nearly $7M In This Sapped Bitcoin-Linked Stock — Also Picks Up Shares In CareDx
Cathie Wood-led Ark Investment Management has bought over 100,000 shares of Jack Dorsey’s Block Inc (NYSE: SQ), valued at over $6.9 million based on Wednesday’s closing price. 
Via Benzinga
CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone
From CareDx, Inc.
Via Business Wire
CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society
From CareDx, Inc.
Via Business Wire
Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30
Reuters Taiwan’s China Airlines Orders 16 Boeing 787s 
Via Benzinga
Cathie Wood Loads Up $3M In This Precision Medicine Firm's Shares Despite Bleak Q2 Results
Cathie Wood-led Ark Investment Management loaded up on 153,917 shares of precision medicine company CareDx Inc (NASDAQ: CDNA), via the ARK Genomic Revolution ETF (NYSE: ARKG< 
Via Benzinga
CareDx and MOTTEP Co-Host Health Equity Summit
From CareDx, Inc.
Via Business Wire
Coinbase To $115? Plus This Analyst Cuts PT On Syros Pharmaceuticals By 67%
Deutsche Bank boosted the price target on FactSet Research Systems Inc. (NYSE: FDS) from $418 to $463. However, Deutsche Bank analyst Faiza Alwy maintained the stock with a Hold rating. FactSet... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.